DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

89.45 4.99 (5.91%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

LGND $89.45 5.91%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $82.90
Previous Close $84.46
Daily Range $82.90 - $89.67
52-Week Range $41.99 - $112.40
Market Cap $1.8B
P/E Ratio 54.49
Dividend (Yield) $0.00 (0.0%)
Volume 390,197
Average Daily Volume 369,304
Current FY EPS $2.81




Drug Makers

Ligand Pharmaceuticals, Inc. (LGND) Description

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. Website:

News & Commentary

The Fastest-Growing Biotech Stocks

Does a minimum of 45% annualized EPS growth over the next five years sound good to you? Then you'll want to have these fastest-growing biotech stocks on your radar.

Ligand, SAGE Captisol Partnership to Also Include SAGE-689

Ligand Expands Captisol License and Supply Agreements with SAGE Therapeutics to Include SAGE-689

Strong And Under The Radar Today: Ligand Pharmaceuticals (LGND)

Don't Be Fooled By The Recent Sell-Off, Ligand Pharmaceuticals Is Strong

Novartis' (NVS) Promacta Label Further Expanded in U.S.

Relative Strength Alert For Ligand Pharmaceuticals

5 Small Biotech Stocks That Could Get Hotter Than the August Heat

These small biotechs hold the potential to add sizzle to investors' portfolios.

Insider Selling Light Despite Market Meltdown: Aetna, O’Reilly, Loews, DR Horton and More

Ligand Pharmaceuticals Tests $100 Level, But Investors Exiting Too Early

See More LGND News...

LGND's Top Competitors

LGND $89.45 (5.91%)
Current stock: LGND
AMGN $142.47 (1.60%)
Current stock: AMGN
GILD $98.28 (0.01%)
Current stock: GILD
BIIB $290.35 (1.06%)
Current stock: BIIB